Form 4 for TYRA Tyra Biosciences, Inc.
Accepted 2024-09-25 00:00:00 ET · period of report 2024-09-23 · accession 0000950170-24-109410 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2024-09-25 | 2024-09-23+ | TYRA | Harris Todd | Pres, CEO, Dir | S - Sale | $24.11 | -11.7K | 1.48M | -0.8% | -$283.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-25 | S | D | 600 | $24.01 | 1,477,873 | D | — | — | (F4) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $24.00 to $24.06. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 2 | Common | Common Stock | 2024-09-24 | S | D | 1,055 | $24.02 | 1,478,473 | D | — | — | (F3) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $24.00 to $24.14. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 3 | Common | Common Stock | 2024-09-23 | S | D | 10,092 | $24.13 | 1,479,528 | D | — | — | (F2) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $24.005 to $24.25. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |